CY1117170T1 - Συνθεση ολιγοσακχαριτων για προληψη ή μειωση του κινδυνου μεταβολικου συνδρομου - Google Patents
Συνθεση ολιγοσακχαριτων για προληψη ή μειωση του κινδυνου μεταβολικου συνδρομουInfo
- Publication number
- CY1117170T1 CY1117170T1 CY20161100102T CY161100102T CY1117170T1 CY 1117170 T1 CY1117170 T1 CY 1117170T1 CY 20161100102 T CY20161100102 T CY 20161100102T CY 161100102 T CY161100102 T CY 161100102T CY 1117170 T1 CY1117170 T1 CY 1117170T1
- Authority
- CY
- Cyprus
- Prior art keywords
- risk
- prevent
- reduce
- metabolic syndrome
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Η παρούσα εφεύρεση αφορά τη χρήση σύνθεσης γαλακτοολιγοσακχαριτών για την πρόληψη ή μείωση του κινδύνου ανάπτυξης μεταβολικού συνδρόμου.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1111452.7A GB2492559B (en) | 2011-07-05 | 2011-07-05 | Composition and method for preventing or reducing the risk of developing a syndrome |
EP12731143.9A EP2729152B1 (en) | 2011-07-05 | 2012-06-20 | Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1117170T1 true CY1117170T1 (el) | 2017-04-05 |
Family
ID=44512110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20161100102T CY1117170T1 (el) | 2011-07-05 | 2016-02-08 | Συνθεση ολιγοσακχαριτων για προληψη ή μειωση του κινδυνου μεταβολικου συνδρομου |
Country Status (24)
Country | Link |
---|---|
US (2) | US11052097B2 (el) |
EP (1) | EP2729152B1 (el) |
JP (1) | JP2014518253A (el) |
KR (1) | KR20140041597A (el) |
CN (2) | CN107744522A (el) |
AR (1) | AR087062A1 (el) |
AU (1) | AU2012203730B2 (el) |
BR (1) | BR112013030308A2 (el) |
CA (1) | CA2838309C (el) |
CY (1) | CY1117170T1 (el) |
DK (1) | DK2729152T3 (el) |
ES (1) | ES2562993T3 (el) |
GB (1) | GB2492559B (el) |
HU (1) | HUE027148T2 (el) |
IL (1) | IL230251A (el) |
MX (1) | MX337612B (el) |
MY (1) | MY173722A (el) |
PL (1) | PL2729152T3 (el) |
PT (1) | PT2729152E (el) |
RU (1) | RU2571079C2 (el) |
TW (1) | TWI461200B (el) |
UA (1) | UA111616C2 (el) |
WO (1) | WO2013005001A1 (el) |
ZA (1) | ZA201308776B (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2492559B (en) * | 2011-07-05 | 2018-07-25 | Clasado Inc | Composition and method for preventing or reducing the risk of developing a syndrome |
GB201319538D0 (en) | 2013-11-05 | 2013-12-18 | Optibiotix Health Ltd | Composition |
KR102029263B1 (ko) * | 2018-05-16 | 2019-11-08 | 주식회사 비피도 | 베타-엘-푸코피라노실-(1→3)-옥시-디-갈락토피라노오스를 포함하는 프리바이오틱스 조성물 |
GB2623336A (en) * | 2022-10-12 | 2024-04-17 | Clasado Res Services Limited | Compositions and uses thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62210965A (ja) | 1986-03-13 | 1987-09-17 | Shokuhin Sangyo Baioriakutaa Syst Gijutsu Kenkyu Kumiai | 低カロリ−飲食品およびその製造方法 |
JP2699470B2 (ja) | 1988-10-19 | 1998-01-19 | 大日本インキ化学工業株式会社 | 食品保存剤及びその製造方法 |
US6368591B2 (en) * | 1998-05-15 | 2002-04-09 | Shanghai Sine Pharmaceutical Corporation Ltd. | Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof |
RU2280447C2 (ru) * | 1999-09-17 | 2006-07-27 | Новартис Аг | Способ лечения нарушений метаболизма, прежде всего диабета или заболеваний или состояний, связанных с диабетом |
JP2003339348A (ja) * | 2002-05-27 | 2003-12-02 | Toyo Shinyaku:Kk | 健康食品 |
GB0315266D0 (en) * | 2003-06-30 | 2003-08-06 | Clasado Inc | Novel galactooligosaccharide composition and the preparation thereof |
JP4384656B2 (ja) * | 2003-06-30 | 2009-12-16 | クラサド インコーポレイテッド | 新規のガラクトシダーゼ酵素活性を生じさせるビフィドバクテリウムビフィダムの新規株 |
DE102005034262A1 (de) * | 2005-07-22 | 2007-01-25 | Bayer Healthcare Ag | Substituierte Pyridocarboxamide II |
WO2008054193A1 (en) * | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Nutritional products that comprise saccharide oligomers |
EP2143341A1 (en) * | 2008-07-08 | 2010-01-13 | Nestec S.A. | Nutritional Composition Containing Oligosaccharide Mixture |
GB0809921D0 (en) * | 2008-05-30 | 2008-07-09 | Clasado Inc | Product and process therefor |
JP5238373B2 (ja) * | 2008-06-25 | 2013-07-17 | 株式会社ヤクルト本社 | 腸間膜脂肪低減剤 |
GB0906983D0 (en) * | 2009-04-23 | 2009-06-03 | Clasado Inc | Novel use |
BRPI0925002A2 (pt) * | 2009-05-27 | 2016-06-21 | Clasado Inc | uso de uma composição para a prevenção de diarréia |
US8951512B2 (en) * | 2010-05-04 | 2015-02-10 | New York University | Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota |
GB2492559B (en) * | 2011-07-05 | 2018-07-25 | Clasado Inc | Composition and method for preventing or reducing the risk of developing a syndrome |
GB201305708D0 (en) * | 2013-03-28 | 2013-05-15 | Clasado Inc | Novel use |
-
2011
- 2011-07-05 GB GB1111452.7A patent/GB2492559B/en active Active
-
2012
- 2012-06-20 MY MYPI2013004143A patent/MY173722A/en unknown
- 2012-06-20 MX MX2013015036A patent/MX337612B/es active IP Right Grant
- 2012-06-20 PL PL12731143T patent/PL2729152T3/pl unknown
- 2012-06-20 DK DK12731143.9T patent/DK2729152T3/en active
- 2012-06-20 HU HUE12731143A patent/HUE027148T2/en unknown
- 2012-06-20 US US14/130,883 patent/US11052097B2/en active Active
- 2012-06-20 CA CA2838309A patent/CA2838309C/en active Active
- 2012-06-20 RU RU2014103800/15A patent/RU2571079C2/ru not_active IP Right Cessation
- 2012-06-20 PT PT127311439T patent/PT2729152E/pt unknown
- 2012-06-20 WO PCT/GB2012/051418 patent/WO2013005001A1/en active Application Filing
- 2012-06-20 CN CN201710948392.8A patent/CN107744522A/zh active Pending
- 2012-06-20 ES ES12731143.9T patent/ES2562993T3/es active Active
- 2012-06-20 UA UAA201400874A patent/UA111616C2/uk unknown
- 2012-06-20 KR KR1020137034556A patent/KR20140041597A/ko not_active Application Discontinuation
- 2012-06-20 EP EP12731143.9A patent/EP2729152B1/en active Active
- 2012-06-20 BR BR112013030308A patent/BR112013030308A2/pt not_active Application Discontinuation
- 2012-06-20 JP JP2014517930A patent/JP2014518253A/ja active Pending
- 2012-06-20 CN CN201280031811.7A patent/CN103648504A/zh active Pending
- 2012-06-26 AU AU2012203730A patent/AU2012203730B2/en active Active
- 2012-07-03 TW TW101123872A patent/TWI461200B/zh not_active IP Right Cessation
- 2012-07-04 AR ARP120102430A patent/AR087062A1/es unknown
-
2013
- 2013-11-21 ZA ZA2013/08776A patent/ZA201308776B/en unknown
- 2013-12-31 IL IL230251A patent/IL230251A/en active IP Right Grant
-
2016
- 2016-02-08 CY CY20161100102T patent/CY1117170T1/el unknown
-
2021
- 2021-07-02 US US17/367,115 patent/US20210330688A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124924T1 (el) | Φαρμακευτικη συνθεση καρβετοκινης | |
CR20150507A (es) | Inhibidores de histona desmetilasas | |
UY34472A (es) | Derivados modificados de 4-fenil-piridina | |
TR201811764T4 (tr) | Kinaz inhibitörleri olarak aminoheteroaril benzamidleri. | |
CR20150120A (es) | Nuevos derivados bicíclicos | |
CR20140501A (es) | Nuevos diazaespirocicloalcanos y azaespirocicloalcanos | |
UY34550A (es) | Bencilpirazoles sustituidos | |
UY34145A (es) | Compuestos inhibidores de metaloenzimas | |
UY34146A (es) | Compuestos inhibidores de metaloenzimas | |
CR20140468A (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
UY34414A (es) | Composiciones hemostáticas | |
CR20140229A (es) | Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona | |
UY34177A (es) | Nuevos compuestos inhibidores de la fosfodiesterasa tipo 10a | |
CR20130539A (es) | Triazolopiridinas | |
CL2012002979A1 (es) | Derivados de n3-sustituido-n1-sulfonil-5-fluorpirimidinona. | |
EA201390081A1 (ru) | Дейтерированный n-этил-n-фенил-1,2-дигидро-4-гидрокси-5-хлор-1-метил-2-оксохинолин-3-карбоксамид, его соли и их применение | |
UY34654A (es) | Inhibidores de la beta-secretasa | |
UY34817A (es) | Tienopirimidinas | |
UY34057A (es) | Inhibidores del virus de la hepatitis c | |
BR112013025866A2 (pt) | formulações com viscosidade reduzida | |
UY34415A (es) | Composiciones hemostáticas | |
CY1120759T1 (el) | Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης | |
BR112014003027A2 (pt) | formulação herbicida melhorada | |
UY34158A (es) | Composicion herbicida | |
UY4153Q (es) | Batería |